FDA NDC Directory · JSON-LD · Markdown

NULOJIX

NDC 0003-0371 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameBELATACEPT
Labeler / ManufacturerE.R. Squibb & Sons, L.L.C.
Marketing categoryBiologic License Application · App BLA125288
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsBELATACEPT (250 mg/1)
Marketing started20110615
Package count1

External sources

Source: openFDA. Public-domain (CC0).